-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
NewAmsterdam Pharma Co N.V. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2023 to Q2 2024.
- NewAmsterdam Pharma Co N.V. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 94.7M shares, a 15.4% increase year-over-year.
- NewAmsterdam Pharma Co N.V. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 82.2M shares, a 333% increase from 2022.
- NewAmsterdam Pharma Co N.V. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 19M shares, a 72.8% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)